Total planned funding: $591,096,239
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $106,372,536 |
Zambia | $102,868,442 |
Mozambique | $51,901,820 |
Tanzania | $48,048,741 |
South Africa | $36,749,025 |
Zimbabwe | $29,468,423 |
Vietnam | $27,332,092 |
Asia Regional Program | $24,871,345 |
Haiti | $19,478,100 |
Rwanda | $19,330,636 |
West Africa Region | $18,148,918 |
Burundi | $13,860,949 |
Botswana | $11,484,283 |
Cambodia | $9,950,000 |
Côte d'Ivoire | $9,370,831 |
Ghana | $8,272,500 |
India | $7,627,954 |
South Sudan | $6,298,967 |
Dominican Republic | $5,598,850 |
Malawi | $5,578,259 |
Indonesia | $5,455,435 |
Democratic Republic of the Congo | $4,933,510 |
Ethiopia | $4,731,400 |
Eswatini | $2,591,755 |
Kenya | $2,496,634 |
China | $2,350,000 |
Uganda | $2,010,000 |
Lesotho | $1,638,960 |
Namibia | $1,497,275 |
Thailand | $478,599 |
enumerations.Philippines | $300,000 |
Organizational Types
NGO | $575,774,802 |
Implementing Agency | $15,321,437 |
Program Areas
Prevention | $185,462,015 |
Care | $146,350,794 |
Treatment | $140,545,420 |
Governance and Systems | $60,141,161 |
Testing | $58,434,555 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $120,726,169 |
HVOP: Sexual Prevention: Other Sexual Prevention | $100,297,585 |
HKID: Care: Orphans and Vulnerable Children | $67,507,270 |
HVCT: Testing: HIV Testing and Counseling | $58,434,555 |
HBHC: Care: Adult Care and Support | $53,599,044 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $37,843,922 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $34,982,081 |
HLAB: Laboratory Infrastructure | $23,330,479 |
HVSI: Strategic Information | $18,791,615 |
OHSS: Health Systems Strengthening | $18,019,067 |
PDTX: Treatment: Pediatric Treatment | $16,395,967 |
HVTB: Care: TB/HIV | $15,143,643 |
PDCS: Care: Pediatric Care and Support | $10,100,837 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,379,481 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $4,487,446 |
HTXD: Treatment: ARV Drugs | $3,423,284 |
HMIN: Biomedical Prevention: Injection Safety | $355,100 |
HVMS: Management and Operations | $162,294 |
HMBL: Biomedical Prevention: Blood Safety | $116,400 |